CN102836191A - Green lucid ganoderma traditional Chinese drug composition and preparation method thereof - Google Patents
Green lucid ganoderma traditional Chinese drug composition and preparation method thereof Download PDFInfo
- Publication number
- CN102836191A CN102836191A CN2011101717728A CN201110171772A CN102836191A CN 102836191 A CN102836191 A CN 102836191A CN 2011101717728 A CN2011101717728 A CN 2011101717728A CN 201110171772 A CN201110171772 A CN 201110171772A CN 102836191 A CN102836191 A CN 102836191A
- Authority
- CN
- China
- Prior art keywords
- green
- lucid ganoderma
- ganoderma lucidum
- traditional chinese
- seu japonicum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention relates to a green lucid ganoderma traditional Chinese drug composition and a preparation method thereof. The traditional Chinese drug composition comprises the following components, by weight, 40-60% of green lucid ganoderma fine powder, 20-30% of green lucid ganoderma spore powder, 8-18% of sanchi, and 8-18% of American cinseng. The preparation method comprises: uniformly mixing the components according to the ratio, carrying out pre-crushing, and carrying out superfine crushing to 300-800 mesh. According to the traditional Chinese drug composition of the present invention, the lucid ganoderma adopts the green lucid ganoderma fine powder with high quality and the green lucid ganoderma spore powder with high quality, the sanchi and the and the American cinseng are matched, and the superfine crushing preparation method is adopted, such that drug effects are completely provided, good treatment effects are provided for treatment of lesions in liver, pancreas, spleen, and other organs, and the green lucid ganoderma traditional Chinese drug composition is applicable for treatments of hepatitis, liver cancer, liver ascites, hepatic cirrhosis, pancreatitis, pancreatic cancer, splenomegaly, and other diseases.
Description
Technical field
The present invention relates to a kind ofly prepare Chinese medicine composition with Ganoderma, particularly the Ganoderma lucidum seu Japonicum in the Ganoderma prepares Ganoderma lucidum seu Japonicum Chinese medicine composition and preparation method thereof.
Background technology
Ganoderma is Herba mesonae chinensis, Herba Cynomorii, the Herba Hylothelephii Verticillati that the Chinese nation is worshipped since ancient times.Shennong's Herbal is classified it as top grade, is described as the king in the medicine.The Ganoderma of putting down in writing in the Li Shizhen (1518-1593 A.D.) Compendium of Material Medica is divided into Ganoderma lucidum (Leyss. Ex Fr.) Karst., Ganoderma lucidum seu Japonicum, Radix Angelicae Dahuricae, Rhizoma Polygonati, black sesame, Ganoderma.Ganoderma contain protein, fat, polysaccharide, inorganic salt, trace element, vitamin, sterol, lecithin, choline, organic acid, organic this, peptidoglycan, plurality of enzymes, alkaloid nutrition and pharmacology composition.According to the clinical confirmation of modern medicine; Ganoderma also has comparatively significant curative effect to diseases such as gastrointestinal, liver, kidney, leukemia, neurasthenia, chronic bronchitis, asthma, allergy except effective in cure for cancer, cerebral hemorrhage, the heart disease of the human three big causes of the death.In addition, Ganoderma also has multiple effect and effects such as strong exquisite appearance, antiinflammatory, analgesia, antibacterial and detoxicating diuresis, clean blood.
The effect of Ganoderma, from whole composition, modern medicine is verified, and Ganoderma truly has following eight effects greatly: (1) antithrombotic forms, and takes the thrombosis that Ganoderma can be dissolved new formation every day, also can dissolve aging and is difficult to dissolved thrombosis; (2) make blood pressure normalization, strengthen hemopoietic function, also effective in cure to leucose and anemia; (3) improve hyperlipidemia; (4) prevent arteriosclerosis; (5) make somatic function such as nervus centralis keep balance; (6) improve immunity; (7) analgesic activity is arranged, can alleviate the pain of cancer or other disease; (8) prevent to wear out, improve the function of the internal organs that fall into a decline.Ganoderma is to adjust function of human body with the effect of whole composition, and the kind of its ingredient is the optimum human body.
" a kind of Chinese medicine composition with health role " of existing Ganoderma Chinese medicine preparation such as Chinese patent 01118618.6.Generally contain Ganoderma in the Chinese medicine composition of Ganoderma and adopt the Ganoderma lucidum (Leyss. Ex Fr.) Karst. of inferior quality basically, and Ganoderma lucidum (Leyss. Ex Fr.) Karst. mainly to act on be to control knot in the heart, the beneficial motive, invigorating middle warmer, supplementing the brain, it can't be administered a lot of organ diseases.So existing Ganoderma Chinese medicine preparation drug effect is relatively poor.
Summary of the invention
The objective of the invention is to overcome the deficiency of above-mentioned prior art, provide a kind of Ganoderma of better quality to make Chinese medicine composition, the pathological changes of organs such as liver, pancreas, spleen is had a good therapeutic effect
Ganoderma lucidum seu Japonicum Chinese medicine composition and preparation method thereof.
Solution of the present invention is: a kind of Ganoderma lucidum seu Japonicum Chinese medicine composition is characterized in that the each component percentage by weight is following:
The smart powder 40-60% of Ganoderma lucidum seu Japonicum,
Ganoderma lucidum seu Japonicum spore powder 20-30%,
Radix Notoginseng 8-18%,
Radix Panacis Quinquefolii 8-18%.
Ganoderma lucidum seu Japonicum is the good kind of quality in the Ganoderma, its medicinal efficacy be protect the liver, toxin expelling, softening hardness and resolving stasis etc., be applicable to the pathological changes of organs such as liver, pancreas, spleen.Adopt the smart powder of Ganoderma lucidum seu Japonicum, Ganoderma lucidum seu Japonicum spore powder to join Radix Notoginseng and Radix Panacis Quinquefolii, diseases such as treatment hepatitis, hepatocarcinoma, hepatic ascites, liver cirrhosis, pancreatitis, cancer of pancreas, splenomegaly are had better curative effect.Powder after the stem that the smart powder of Ganoderma lucidum seu Japonicum is a Ganoderma lucidum seu Japonicum cap spore is pulverized.
The smart grain weight amount of Ganoderma lucidum seu Japonicum is 2:1 with the ratio of Ganoderma lucidum seu Japonicum spore powder weight in the solution of the present invention, its best results.
The method for preparing of above-mentioned Ganoderma lucidum seu Japonicum Chinese medicine composition is characterized in carrying out precomminution behind the each component mixing with said ratio, then micronizing to 300-800 order.Consider that from curative effect and economy micronizing to 500-700 order is best.
Advantage of the present invention: the Ganoderma in the Chinese medicine composition of the present invention is adopted quality smart powder of Ganoderma lucidum seu Japonicum and Ganoderma lucidum seu Japonicum spore powder preferably; Be equipped with Radix Notoginseng and Radix Panacis Quinquefolii; And the method for preparing of employing micronizing; Give full play to efficacy of drugs, the pathological changes of treating organs such as liver, pancreas, spleen is had a good therapeutic effect, be suitable for treatment of diseases such as hepatitis, hepatocarcinoma, hepatic ascites, liver cirrhosis, pancreatitis, cancer of pancreas, splenomegaly.
The specific embodiment
The embodiment of the invention 1: a kind of Ganoderma lucidum seu Japonicum Chinese medicine composition, the each component percentage by weight is following:
The smart powder 50% of Ganoderma lucidum seu Japonicum,
Ganoderma lucidum seu Japonicum spore powder 25%,
Radix Notoginseng 13%,
Radix Panacis Quinquefolii 12%.
Its preparation method is to carry out precomminution behind the each component mixing with said ratio, then micronizing to 500-700 order.
Clinical practice is following:
Luo, man, 34 years old, the Yan Bianshi of Jilin Province work, home address, Yanting County.The hospital inspection through the West China, Sichuan: right liver massive hepatocarcinoma (14.5*10.5*9cm).On October 9th, 2010 is hospital in the West China, Sichuan, makes right liver tumor excision under the general anesthesia of liver and gall pancreas surgery, is in hospital 12 days, the recuperation of going home.Pale complexion, lethargy, moving difficulty.Three courses of treatment of left hospital on October 22nd, 2010 second day clothes Ganoderma lucidum seu Japonicum Chinese medicine composition, Ganoderma semen multiplex powder, day clothes 4 times, each 2 grams.After three months, weight increase 16 jin, alpha-fetoprotein is reduced to 7ug/ml from 400ug/ml.Return original unit's work, this patient full recovery basically is healthy.
Embodiment 2: a kind of Ganoderma lucidum seu Japonicum Chinese medicine composition, and the each component percentage by weight is following:
The smart powder 60% of Ganoderma lucidum seu Japonicum,
Ganoderma lucidum seu Japonicum spore powder 20%,
Radix Notoginseng 11%,
Radix Panacis Quinquefolii 9%.
Its preparation method is to carry out precomminution behind the each component mixing with said ratio, then micronizing to 300-500 order.
[0016] clinical practice is following:
The king so-and-so, man, 56 years old, Santai County work, home address, Santai County.Hospital's consultation of doctors pathological replacement through the West China, Sichuan: " right stones in intrahepatic bile duct wall, in the bile duct, the extrahepatic bile ducts neoplasm " the papillary adenocarcinoma chronic cholecystitis, companion's papillary adenocarcinoma appearance hypertrophy and focal necrosis.404 hospitals make obstructive jaundice, make the biliary tract surgical drainage in Mianyang, get the necrotic lesion thing and send the West China sick inspection, are in hospital and leave hospital in 15 days, arrange chemotherapy also inoperative even the hospital expert group is said papillary carcinoma, put, chemotherapy.Patient's postoperative just began to take two courses of treatment of Ganoderma lucidum seu Japonicum Chinese medicine composition, Ganoderma semen multiplex powder, day clothes 4 times, each 2 grams in second day.The period in a medicine patient has a meal, sleeps, takes a walk and ordinary person hospital.Drug withdrawal three months at present, health does not still have uncomfortable part, and it is also normal fully to look into liver function, explains that patient body gets well basically.
Claims (4)
1. Ganoderma lucidum seu Japonicum Chinese medicine composition is characterized in that the each component percentage by weight is following:
The smart powder 40-60% of Ganoderma lucidum seu Japonicum,
Ganoderma lucidum seu Japonicum spore powder 20-30%,
Radix Notoginseng 8-18%,
Radix Panacis Quinquefolii 8-18%.
2. Ganoderma lucidum seu Japonicum Chinese medicine composition according to claim 1 is characterized in that the smart grain weight amount of Ganoderma lucidum seu Japonicum in the compositions and the ratio of Ganoderma lucidum seu Japonicum spore powder weight are 2:1.
3. the method for preparing of Ganoderma lucidum seu Japonicum Chinese medicine composition according to claim 1 is characterized in that carrying out precomminution behind the each component mixing with said ratio, then micronizing to 300-800 order.
4. the method for preparing of Ganoderma lucidum seu Japonicum Chinese medicine composition according to claim 3 is characterized in that micronizing to 500-800 order.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101717728A CN102836191A (en) | 2011-06-24 | 2011-06-24 | Green lucid ganoderma traditional Chinese drug composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101717728A CN102836191A (en) | 2011-06-24 | 2011-06-24 | Green lucid ganoderma traditional Chinese drug composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102836191A true CN102836191A (en) | 2012-12-26 |
Family
ID=47364094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101717728A Pending CN102836191A (en) | 2011-06-24 | 2011-06-24 | Green lucid ganoderma traditional Chinese drug composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102836191A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383210A (en) * | 2014-11-29 | 2015-03-04 | 刘娟 | Medicine for assisting post-hepatectomy recovery |
| CN104546966A (en) * | 2015-01-27 | 2015-04-29 | 珠海道尔生物科技发展有限责任公司 | Anti-tumour traditional Chinese medicine composition with immunologic function regulation function |
| CN105169105A (en) * | 2015-10-13 | 2015-12-23 | 宁波御坊堂生物科技有限公司 | Chinese medicinal preparation having functions of preventing tumors, nourishing yin and stomach and enhancing immunity and preparation method thereof |
| CN109394809A (en) * | 2018-12-21 | 2019-03-01 | 吉林省北域西洋参研究有限公司 | A kind of Chinese medicine composition and its preparation method and application improving immunity |
| CN113713013A (en) * | 2021-08-20 | 2021-11-30 | 河北御芝林生物科技有限公司 | Composition for resisting liver injury and preparation method thereof |
-
2011
- 2011-06-24 CN CN2011101717728A patent/CN102836191A/en active Pending
Non-Patent Citations (6)
| Title |
|---|
| 史艳宇等: "西洋参有效部位的抗肿瘤作用研究 ", 《中国药理学通报》 * |
| 史艳宇等: "西洋参有效部位的抗肿瘤作用研究", 《中国药理学通报》, no. 01, 30 January 2005 (2005-01-30), pages 75 - 78 * |
| 孔令谦: "《排毒养生堂》", 31 December 2007 * |
| 孙兰等: "三七保肝作用及其机理研究进展 ", 《中医药信息》 * |
| 孙兰等: "三七保肝作用及其机理研究进展", 《中医药信息》, no. 01, 10 January 2006 (2006-01-10), pages 17 - 19 * |
| 陈国良等: "《灵芝治百病》", 31 December 1997 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383210A (en) * | 2014-11-29 | 2015-03-04 | 刘娟 | Medicine for assisting post-hepatectomy recovery |
| CN104546966A (en) * | 2015-01-27 | 2015-04-29 | 珠海道尔生物科技发展有限责任公司 | Anti-tumour traditional Chinese medicine composition with immunologic function regulation function |
| CN104546966B (en) * | 2015-01-27 | 2017-09-01 | 珠海道尔生物科技发展有限责任公司 | A kind of antitumor Chinese with Immunologic Functions |
| CN105169105A (en) * | 2015-10-13 | 2015-12-23 | 宁波御坊堂生物科技有限公司 | Chinese medicinal preparation having functions of preventing tumors, nourishing yin and stomach and enhancing immunity and preparation method thereof |
| CN109394809A (en) * | 2018-12-21 | 2019-03-01 | 吉林省北域西洋参研究有限公司 | A kind of Chinese medicine composition and its preparation method and application improving immunity |
| CN113713013A (en) * | 2021-08-20 | 2021-11-30 | 河北御芝林生物科技有限公司 | Composition for resisting liver injury and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102836191A (en) | Green lucid ganoderma traditional Chinese drug composition and preparation method thereof | |
| CN101385843B (en) | Nano medicine magnet therapy plaster for relieving the swelling and easing pain | |
| CN102579940B (en) | Chinese medicine composition for curing infantile diarrhea and applied on navel | |
| CN1323711C (en) | Chinese medicine for treating liver cancer and carcinoma of pancreas | |
| CN102579999B (en) | Medicine for treating carcinous fever and preparation method thereof | |
| CN111097030A (en) | Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof | |
| CN102824469B (en) | Detoxification traditional Chinese medicine and preparation method thereof | |
| CN105456428A (en) | Traditional Chinese medicine formula for inhibiting regrowth of tumor cells and preparation method thereof | |
| CN104173978A (en) | Heat clearing and cold dispelling traditional Chinese medicine composition for treating winter cold fever and preparation method thereof | |
| CN107496525A (en) | A kind of Chinese medicine composition for treating cancer pain disease and its application | |
| CN100425252C (en) | Medicine for treating leukopenia | |
| CN102920933A (en) | Chinese medicinal preparation for treating chronic obstructive pulmonary diseases | |
| CN102813799A (en) | Medicament for treating intractable skin disease | |
| CN102309686A (en) | Medicinal composition for rehabilitation and application thereof | |
| CN101690746B (en) | Chinese herbal preparation for treating soft tissue injuries and fractures | |
| CN102836193A (en) | Lucid ganoderma composite spore powder and preparation method thereof | |
| CN103768480A (en) | Traditional Chinese medicine for treating prosopospasm and preparation method thereof | |
| CN1730006A (en) | Pharmaceutical composition for treating lung and kidney deficiency and qi, yin insufficiency and preparation method thereof | |
| CN101011512A (en) | Medicine for treating digestive tract tumour and its preparing process | |
| CN102836222A (en) | Black lucid ganoderma traditional Chinese drug composition and preparation method thereof | |
| CN101185697B (en) | Ointment medicine for treating anal fissure | |
| CN105434533A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN105770515A (en) | Traditional Chinese medicinal composition for treating prostatitis and preparation method of traditional Chinese medicinal composition | |
| CN102836192A (en) | Purple lucid ganoderma traditional Chinese drug composition and preparation method thereof | |
| CN100364586C (en) | Medicine for treating digestive tract tumor and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121226 |